502 related articles for article (PubMed ID: 6311898)
21. Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus.
Ginsburg WW; Finkelman FD; Lipsky PE
Clin Exp Immunol; 1979 Jan; 35(1):76-88. PubMed ID: 154983
[TBL] [Abstract][Full Text] [Related]
22. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
Moutsopoulos HM; Fauci AS
J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
[TBL] [Abstract][Full Text] [Related]
23. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis.
Tosato G; Steinberg AD; Yarchoan R; Heilman CA; Pike SE; De Seau V; Blaese RM
J Clin Invest; 1984 Jun; 73(6):1789-95. PubMed ID: 6327772
[TBL] [Abstract][Full Text] [Related]
24. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
25. Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations.
Meuer SC; Cooper DA; Hodgdon JC; Hussey RE; Morimoto C; Schlossman SF; Reinherz EL
J Immunol; 1983 Sep; 131(3):1167-72. PubMed ID: 6309959
[TBL] [Abstract][Full Text] [Related]
26. IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro.
Volk HD; Diamantstein T
Clin Exp Immunol; 1986 Dec; 66(3):525-31. PubMed ID: 2952381
[TBL] [Abstract][Full Text] [Related]
27. Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction.
Sagawa A; Abdou NI
J Clin Invest; 1978 Oct; 62(4):789-96. PubMed ID: 308952
[TBL] [Abstract][Full Text] [Related]
28. B cell activity and regulatory T cell function in systemic lupus erythematosus by human B cell colony formation.
Otsuka T; Okamura S; Niho Y; Kusaba T
J Rheumatol; 1985 Jun; 12(3):508-13. PubMed ID: 2864442
[TBL] [Abstract][Full Text] [Related]
29. Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.
Sakane T; Steinberg AD; Reeves JP; Green I
J Clin Invest; 1979 May; 63(5):954-65. PubMed ID: 312810
[TBL] [Abstract][Full Text] [Related]
30. Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE).
Morimoto C
Clin Exp Immunol; 1978 Apr; 32(1):125-33. PubMed ID: 352583
[TBL] [Abstract][Full Text] [Related]
31. Defective EBV-specific suppressor T-cell function in rheumatoid arthritis.
Tosato G; Steinberg AD; Blaese RM
N Engl J Med; 1981 Nov; 305(21):1238-43. PubMed ID: 6270556
[TBL] [Abstract][Full Text] [Related]
32. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.
Birx DL; Redfield RR; Tosato G
N Engl J Med; 1986 Apr; 314(14):874-9. PubMed ID: 3005862
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with anti-class II antibody.
Tanaka Y; Shirakawa F; Ota T; Suzuki H; Eto S; Yamashita U
J Immunol; 1988 Feb; 140(3):761-7. PubMed ID: 3276779
[TBL] [Abstract][Full Text] [Related]
34. Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells.
Sakane T; Takada S; Suzuki N; Tsuchida T; Murakawa Y; Ueda Y
J Immunol; 1986 Dec; 137(12):3809-13. PubMed ID: 2946769
[TBL] [Abstract][Full Text] [Related]
35. Studies of immune abnormalities in systemic lupus erythematosus.
Steinberg AD; Smith HR; Laskin CA; Steinberg BJ; Smolen JS
Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):101-10. PubMed ID: 6213146
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous immunoglobulin A secretion and lack of mitogen-responsive B cells in systemic lupus erythematosus.
Saiki O; Saeki Y; Kishimoto S
J Clin Invest; 1985 Nov; 76(5):1865-70. PubMed ID: 3932473
[TBL] [Abstract][Full Text] [Related]
37. Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus.
Nakamura M; Burastero SE; Ueki Y; Larrick JW; Notkins AL; Casali P
J Immunol; 1988 Dec; 141(12):4165-72. PubMed ID: 2848890
[TBL] [Abstract][Full Text] [Related]
38. Impaired antigen-specific suppressor cell activity in patients with systemic lupus erythematosus.
Gladman D; Keystone E; Urowitz M; Cane D; Poplonski L
Clin Exp Immunol; 1980 Apr; 40(1):77-82. PubMed ID: 6156046
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
40. Transient immunodeficiency during asymptomatic Epstein-Barr virus infection.
Bowen TJ; Wedgwood RJ; Ochs HD; Henle W
Pediatrics; 1983 Jun; 71(6):964-7. PubMed ID: 6304613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]